Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Natera to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
QuoteMedia Announces Accelerated Revenue Growth for Q3 2020
-
electroCore to Participate in Upcoming Virtual Investor Conferences
-
MiMedx To Present At Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Open Lending (LPRO) PT Raised to $35 at Canaccord Genuity, Following Earnings
-
Skeena Resources Announces Pricing of Upsized C$40.0 Million Common Share Public Offering
-
ATEC to Participate in Upcoming Investor Conferences
-
Sustainable Produce Urban Delivery Inc. Engages Canaccord Genuity Corp. and Desjardins Securities Inc. for up to C$30 Million Private Placement Financing
-
Perimeter Medical Imaging AI to Present at Upcoming Virtual Investor Conferences
-
Quidel to Present at Upcoming Conferences
-
BigCommerce (BIGC) Announces Launch of Follow-on Public Offering
-
BigCommerce Announces Launch of Follow-on Public Offering
-
Gatos Silver Announces Full Exercise of Underwriters’ Over-Allotment Option
-
Profound Medical to Participate in November Virtual Investor Healthcare Conferences
-
Profound Medical to Participate in November Virtual Investor Healthcare Conferences
-
Clinical Genomics to Present at 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum
-
Skeena Resources Announces Overnight Marketed Public Offering
-
Transaction in Own Shares
-
BioMedNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Selected to Present at Upcoming Investor Conferences
-
Metallic Minerals Announces C$2.5 Million Private Placement of Flow-Through Common Shares
-
The Bitcoin Fund by 3iQ Completes Offering
-
PIMCO Tactical Income Fund Announces Exercise of Over-Allotment Option
-
LexaGene to Present at Two Upcoming Investor Conferences
-
Organigram (OGI) Announces $60 Million Underwritten Public Offering
-
Organigram Announces $60 Million Underwritten Public Offering
-
TELA Bio to Participate at Upcoming Investor Conferences
-
TELA Bio to Participate at Upcoming Investor Conferences
-
CareDx to Participate at Upcoming Conferences
-
Net Asset Value(s)
-
Insulet to Present at Upcoming Investor Conferences
-
Director Declaration
-
CloudMD Announces Closing of Oversubscribed $37.26 Million Bought Deal Public Offering
-
Exagen Inc. To Participate in November Investor Conferences
-
Exagen Inc. To Participate in November Investor Conferences
-
Schultze Special Purpose Acquisition Corp. and Clever Leaves, a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator, Announce Revised Transaction Terms
-
Canaccord Genuity Group Inc. Reports Second Quarter Fiscal 2021 Results
-
Inari Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Penumbra, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Issue of Equity
-
Sientra to Participate in Upcoming Virtual Investor Conferences
-
i3 Energy PLC Announces Commencement of Trading on Toronto Stock Exchange
-
Form 8.3 - [RSA Insurance Group plc] - (CGWL)
-
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
-
Intersect ENT to Participate at Upcoming Investor Conferences
-
Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update
-
Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update
-
Acutus Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
GlobeX Data Ltd. Closes Private Placement
-
Cybin Completes Reverse Take-Over Transaction
-
Planet 13 Holdings Inc. Announces Closing of C$28.8 Million Bought Deal Public Offering

